2025 22nd Annual Biopharma Manufacturing Survey--BioPlan

1. Introduction

2025 BioPlan's 22nd Annual Survey--Biopharmaceutical Manufacturing

For over 20 years, we continue to be the leader in providing the biopharma industry's most comprehensive benchmarking analysis.

We invite you to participate in our 22nd Annual Survey in Biopharmaceutical Manufacturing! We analyze advances in bioprocessing, new technologies and emerging trends, and your input is critical as we evaluate and share back these important findings with our participants!

For all completed, qualified surveys, we'll send an Amazon e-gift card, a copy of the summary results, and our 2025 Top Trends in Biomanufacturing White Paper (all mid-2025).

Question Title

* 1. TRENDS

What is the SINGLE most important biomanufacturing trend/operational area the industry must focus efforts on in 2025?

Process design and scale-up

Fill-Finish Technologies

Single-Use Systems: Implementation and Integration

Automation

Capacity Issues

Manufacturing Cost Reductions

Outsourcing

Single-Use Systems: Better devices

Biosimilars/Biogenerics

Cell Therapy

ADC (Antibody Drug Conjugates)

Upstream: Processing Advances

Manufacturing Productivity/Efficiency

Viral and Gene Therapies

Continuous BioProcessing - Downstream

Materials Sourcing/Raw Materials Management

Downstream: Processing Advances

Continuous BioProcessing - Upstream

5% of survey complete.

Question Title

* 1. TRENDSWhat is the SINGLE most important biomanufacturing trend/operational area the industry must focus efforts on in 2025?

* 1. TRENDS

What is the SINGLE most important biomanufacturing trend/operational area the industry must focus efforts on in 2025?